Myriad Genetics (MYGN) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY25 Guidance
Go back to Myriad Genetics (MYGN) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY25 Guidance| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.89 | 52 Week High | $45.34 | |||
| Open | $3.89 | 52 Week Low | $15.92 | |||
| Day High | $3.89 | P/E | 1.67 | |||
| Day Low | $3.89 | EPS | $2.33 | |||
| Volume | 50 | |||||
